ABBV vs MDT
By Alex · Tickerpine
AbbVie Inc. vs Medtronic plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | MDT |
|---|---|---|
| Price | $253.35 | $80.98 |
| Market cap | $447.62B | $103.66B |
| P/E ratio | 123.6 | 21.7 |
| ROE | — | 9.84% |
| Profit margin | 5.79% | 13.20% |
| Revenue growth | 12.40% | 9.90% |
| Dividend yield | 2.73% | 3.56% |
| Beta | 0.31 | 0.60 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs MDT in plain English
- ABBV is the bigger company — about 4.3× the market cap of MDT.
- MDT is cheaper on earnings (P/E 21.7 vs 123.6).
- ABBV is growing revenue faster (12% vs 10%).
- MDT has the higher dividend yield (3.56% vs 2.73%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
MDT return calculator
See what $1,000 in Medtronic plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.